MedTrace Logo

Macrolides in COPD- Bronchiectasis Overlap

NCT04215172 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2020-07-22

No results posted yet for this study

Summary

To assess safety of long-term macrolide therapy in patients with COPD-bronchiectasis overlap syndrome And evaluate its efficacy in treating COPD-bronchiectasis overlap syndrome regarding change in clinical, functional and microbiological profile.

To define the, clinical, radiological, functional and microbiological patterns of patients with COPD-bronchiectasis overlap syndrome

Conditions

Interventions

DRUG

Macrolides

administration of azithromycin three times weekly for six months

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-08-01
Primary Completion
2022-01-01
Completion
2022-07-01
FDA Drug
Yes

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04215172 on ClinicalTrials.gov